WELL Health Technologies Corp. (TSE:WELL) Receives C$8.08 Consensus PT from Analysts

WELL Health Technologies Corp. (TSE:WELL) has earned an average rating of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is C$8.08.

A number of brokerages have issued reports on WELL. Scotiabank cut their price objective on shares of WELL Health Technologies from C$8.00 to C$7.00 and set an “outperform” rating for the company in a report on Wednesday, April 16th. CIBC lowered their price target on WELL Health Technologies from C$7.00 to C$5.00 and set a “neutral” rating for the company in a research report on Wednesday, April 16th. TD Securities reduced their target price on WELL Health Technologies from C$8.50 to C$7.50 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. Ventum Financial reduced their target price on WELL Health Technologies from C$8.00 to C$7.60 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. Finally, Royal Bank of Canada cut their price target on WELL Health Technologies from C$8.50 to C$7.50 and set an “outperform” rating on the stock in a research note on Monday, March 31st.

WELL Health Technologies Price Performance

Shares of TSE:WELL opened at C$4.19 on Friday. WELL Health Technologies has a fifty-two week low of C$3.63 and a fifty-two week high of C$7.36. The business has a 50-day simple moving average of C$4.34 and a two-hundred day simple moving average of C$5.48. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. The firm has a market cap of C$1.05 billion, a price-to-earnings ratio of 14.20, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.